Commentary: Systemic lupus erythematosus and cardiovascular disease: A Mendelian randomization study

Sophia Kerns; Katherine A Owen; Jessica Kain; Peter E Lipsky

doi:10.3389/fimmu.2022.1075400

Commentary: Systemic lupus erythematosus and cardiovascular disease: A Mendelian randomization study

Front Immunol. 2022 Dec 8:13:1075400. doi: 10.3389/fimmu.2022.1075400. eCollection 2022.

Authors

Sophia Kerns^{1

2}, Katherine A Owen^{1

2}, Jessica Kain^{1

2}, Peter E Lipsky^{1

2}

Affiliations

¹ AMPEL BioSolutions, LLC, Charlottesville, VA, United States.
² ReImagined Lupus Investigation, Treatment and Education (RILITE) Research Institute, Charlottesville, VA, United States.

No abstract available

Keywords: GWAS - genome-wide association study; Mendelian randomization; cardiovascular disease (CVD); heart failure; systemic lupus - erythematosus.

Publication types

Research Support, Non-U.S. Gov't
Comment

MeSH terms

Arthritis, Rheumatoid*
Cardiovascular Diseases* / epidemiology
Cardiovascular Diseases* / genetics
Humans
Lupus Erythematosus, Systemic* / genetics
Mendelian Randomization Analysis